If you liked this article you might like

Celgene Is Heading Even Higher -- Here's How to Trade It Now

Celgene Is Heading Even Higher -- Here's How to Trade It Now

Hep C Business Slow-Down Could Hamper Bristol-Myers' Future

Hep C Business Slow-Down Could Hamper Bristol-Myers' Future

Celgene Beats Estimates, Raises Earnings Outlook

Celgene Beats Estimates, Raises Earnings Outlook

Jim Cramer Says Oncology Drug Franchises Helping Both Celgene and Bristol-Myers

Jim Cramer Says Oncology Drug Franchises Helping Both Celgene and Bristol-Myers